Daily News header
Press Release

Moody's Analytics US Macro Outlook: The Fiscal Countdown Begins

NEW YORK - (BUSINESS WIRE) - Moody's Analytics, a leading independent provider of economic forecasting, today released Chief Economist Mark Zandi's US economic outlook for November. According to "U.S. Macro Outlook: The Fiscal Countdown Begins," unless the Obama administration and House Republicans can agree on federal fiscal policy, the economy will be in recession by the spring of 2013.

Moody's Analytics baseline outlook assumes that negotiations may have to extend into 2013, which will raise uncertainty and cause growth to nearly stall out in the first quarter of 2013. Once something has been agreed upon, real GDP growth of about 2% in 2013, will nearly double in 2014, and stay near 4% in 2015. Job growth will accelerate from approximately 2 million jobs per year today to nearly 3 million, and unemployment will fall definitively as job creation picks up.

"Going over the fiscal cliff or breaking the debt ceiling would have a widespread impact on the economy, nearly all of it negative. Given the suffering that would occur if policymakers don't act, therefore, the most plausible outcome is that they will," said Zandi.

To read the complete release at NewsBlaze,
Moody's Analytics US Macro Outlook: The Fiscal Countdown Begins,
Click here

Related Business Wire News

ON Semiconductor , driving innovation in energy efficiency, has been awarded a 2012 Best Project Collaboration Award from Yanfeng Visteon Group , a leading automotive component supplier in China.
Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Centerline Holding Company Over the Proposed Sale of the Company to Hunt Companies, Inc.
Faruqi & Faruqi, LLP Launches An Investigation Against OXiGENE, Inc. For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
Identity Security Company Ranks Among Top 100 Organizations that Excel in Benefits, Career Development, Diversity, Retention and Training
The suit alleges defendants issued false statements concerning the viability of Dynavax's lead product candidate, HEPLISAV, resulting in its stock trading at inflated prices.
InvenSense to Exhibit at Mobile Asia Expo 2013

 

NewsBlaze Writers Of The Month



Popular Stories This Month

newsletter logo

NewsBlaze
Copyright © 2004-2013 NewsBlaze Pty. Ltd.
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice               Press Room   |    Visit NewsBlaze Mobile Site